GlassScriptPhysician profile
Brian P Quinn
NPI 1447399100
$6,119.26
in general payments reported to CMS, 2019-2025
26 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $790 · 2021: $550 · 2022: $1,051 · 2023: $876 · 2024: $750 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,179.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $849.06 | 2019-2025 | Supera, Piccolo Xpress, Swift-Lock |
| Smith+Nephew, INC. | $700.47 | 2019-2021 | |
| Medtronic, INC. | $412.48 | 2023-2025 | Intellis Adaptivestim, Hawkone |
| Horizon Therapeutics Plc | $394.84 | 2019-2023 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $390.52 | 2022 | |
| Abbvie INC. | $366.95 | 2019 | |
| Bioventus LLC | $365.85 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $283.28 | 2022-2023 | Senza |
| Royal Biologics, INC. | $280.14 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $249.84 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $247.43 | 2023 | Nuzyra |
| Medtronic Vascular, INC. | $227.02 | 2019-2020 | |
| Polynovo North America LLC | $171.63 | 2025 | Novosorb Btm |
| Amgen INC. | $150.00 | 2024 | Krystexxa |
| Advanced Oxygen Therapy INC. | $148.36 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $147.40 | 2022-2024 | |
| Trilliant Surgical LLC. | $124.97 | 2020 | |
| Grt US Holding, INC. | $121.17 | 2022 | |
| Pfizer INC. | $119.04 | 2019 | |
| Celularity INC. | $111.94 | 2020 | |
| Organogenesis INC. | $109.96 | 2023 | Puraply |
| Forte Bio-Pharma LLC | $62.06 | 2022 | |
| Seapearl East, INC | $29.86 | 2023 | |
| Epi Health, LLC | $20.37 | 2022 | |
| Integra Lifesciences Corporation | $19.47 | 2020 | |
| Acumed LLC | $15.15 | 2023 | Acumed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.